M&T Bank’s TherapeuticsMD TXMD Stock Holding History

M&T Bank’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-208	Closed	-$64K	–	2198
2015 Q1	$64K	Buy	+208	New	+$50.8K	﹤0.01%	1882
2014 Q4	–	Sell	-237	Closed	-$55K	–	2242
2014 Q3	$55K	Buy	+237	New	+$59.7K	﹤0.01%	2077

Other funds holding TXMD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

M&T Bank's TXMD Position: Q2 2015 in Review

M&T Bank sold out of TherapeuticsMD (TXMD) in Q2 2015, closing a stake of 208 shares — an estimated $64K sold.

M&T Bank first reported a position in TXMD in Q3 2014 and held it in 2 quarters. The position peaked at $64K in Q1 2015. 115 funds tracked by Wall St. Rank hold TXMD as of Q2 2015.

M&T Bank reported no remaining TherapeuticsMD position as of Q2 2015 after selling out during the quarter.
M&T Bank sold 208 TherapeuticsMD shares in Q2 2015, an estimated $64K.
M&T Bank first reported a position in TherapeuticsMD in Q3 2014 and held it in 2 quarters.
M&T Bank's TherapeuticsMD position peaked at $64K in Q1 2015.
115 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2015.

Based on M&T Bank's 13F filing for Q2 2015, filed 14 Aug 2015.